Gerrit van der Steege

3.6k citations

63 papers · 2.4k indexed · h-index 28

Co-authors: Ilja M. Nolte Gerard J. te Meerman Elvira Oosterom Hans Scheffer Dirk J. van Veldhuisen Rudolf A. de Boer Alistair S. Hall Adriaan A. Voors
Topics: Neurogenetic and Muscular Disorders Research (9 papers)Inflammatory Bowel Disease (9 papers)RNA modifications and cancer (7 papers)
Cited by: Aging Genetics Immunology
Journals: The Lancet Journal of Clinical Oncology Gastroenterology
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Gerrit van der Steege

60 papers receiving 2.3k citations

Peers

Countries citing papers authored by Gerrit van der Steege

Since Specialization

Citations

This map shows the geographic impact of Gerrit van der Steege's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerrit van der Steege with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerrit van der Steege more than expected).

Fields of papers citing papers by Gerrit van der Steege

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerrit van der Steege. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerrit van der Steege. The network helps show where Gerrit van der Steege may publish in the future.

Co-authorship network of co-authors of Gerrit van der Steege

This figure shows the co-authorship network connecting the top 25 collaborators of Gerrit van der Steege. A scholar is included among the top collaborators of Gerrit van der Steege based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerrit van der Steege. Gerrit van der Steege is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22 2008 ·British Journal of Haematology ·Marijke Niens,Lydia Visser,Ilja M. Nolte,Gerrit van der Steege,Arjan Diepstra,Pablo Cordano,Ruth F. Jarrett,Gerard J. te Meerman,Sibrand Poppema,Anke van den Berg	89
2	Possible Association Between Telomere Length and Renal Dysfunction in Patients With Chronic Heart Failure 2008 ·The American Journal of Cardiology ·Pim van der Harst,Liza S. M. Wong,Rudolf A. de Boer,Scott Brouilette,Gerrit van der Steege,Adriaan A. Voors,Alistair S. Hall,Nilesh J. Samani,John Wikstrand,Wiek H. van Gilst,Dirk J. van Veldhuisen	42
3	Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5 2008 ·Inflammatory Bowel Diseases ·Rinse K. Weersma,Lu Zhou,Ilja M. Nolte,Gerrit van der Steege,Hendrik M. van Dullemen,Elvira Oosterom,Lisette Bok,Maikel P. Peppelenbosch,Klaas Nico Faber,Jan H. Kleibeuker,Gerard Dijkstra	29
4	PROS1analysis in 87 pedigrees with hereditary protein S deficiency demonstrates striking genotype-phenotype associations 2008 ·Human Mutation ·Min Ki ten Kate,Mathieu Platteel,René Mulder,P. Terpstra,Gerry A. F. Nicolaes,Pieter H. Reitsma,Gerrit van der Steege,Jan van der Meer	23
5	Genetic susceptibility has a more important role in pediatric-onset Crohnʼs disease than in adult-onset Crohnʼs disease 2007 ·Inflammatory Bowel Diseases ·Lissy de Ridder,Rinse K. Weersma,Gerard Dijkstra,Gerrit van der Steege,Marc A. Benninga,Ilja M. Nolte,Jan A. J. M. Taminiau,Daniël W. Hommes,Pieter Stokkers	79
6	Telomere Length of Circulating Leukocytes Is Decreased in Patients With Chronic Heart Failure 2007 ·Journal of the American College of Cardiology ·Pim van der Harst,Gerrit van der Steege,Rudolf A. de Boer,Adriaan A. Voors,Alistair S. Hall,Marcel Mulder,Wiek H. van Gilst,Dirk J. van Veldhuisen	223
7	The Human Leukocyte Antigen Class I Region Is Associated with EBV-Positive Hodgkin's Lymphoma: HLA-A and HLA Complex Group 9 Are Putative Candidate Genes 2006 ·Cancer Epidemiology Biomarkers & Prevention ·Marijke Niens,Anke van den Berg,Arjan Diepstra,Ilja M. Nolte,Gerrit van der Steege,Alice Gallagher,G. Malcolm Taylor,Ruth F. Jarrett,Sibrand Poppema,Gerard J. te Meerman	26
8	Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism 2006 ·Genes and Immunity ·Ymkje Stienstra,Tjip S. van der Werf,Elvira Oosterom,Ilja M. Nolte,Winette T.A. van der Graaf,Samuel Etuaful,Pratima L. Raghunathan,Ellen A. Spotts Whitney,Edwin Ampadu,Kwame Asamoa,Erasmus Klutse,Gerard J. te Meerman,Jordan W. Tappero,David A. Ashford,Gerrit van der Steege	59
9	CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: An association study and pooled analysis 2006 ·Digestive and Liver Disease ·Liekele E. Oostenbrug,Ilja M. Nolte,Elvira Oosterom,Gerrit van der Steege,G.J. te Meerman,Hendrik M. van Dullemen,Joost P.H. Drenth,Dirk J. de Jong,K Linde,P. L. M. Jansen,Jan H. Kleibeuker	24
10	Re-analysis of the Xq27–Xq28 region suggests a weak association of an X-linked gene with sporadic testicular germ cell tumour without cryptorchidism 2006 ·European Journal of Cancer ·Martijn F. Lutke Holzik,Harald J. Hoekstra,Rolf H. Sijmons,D J A Sonneveld,Gerrit van der Steege,Dirk Th. Sleijfer,I Nolte	6
11	No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factors 2005 ·European Journal of Cancer ·Mirjam M. de Jong,Ilja M. Nolte,Gerard J. te Meerman,Winette T.A. van der Graaf,Elvira Oosterom,Marcel Bruinenberg,Gerrit van der Steege,Jan C. Oosterwijk,Annemarie H. van der Hout,H. Marike Boezen,Michael Schaapveld,Jan H. Kleibeuker,Elisabeth G.E. de Vries	11
12	Colorectal cancer and the CHEK2 1100delC mutation 2005 ·Genes Chromosomes and Cancer ·Mirjam M. de Jong,Ilja M. Nolte,Gerard J. te Meerman,Winette T.A. van der Graaf,Marcel Mulder,Gerrit van der Steege,Marcel Bruinenberg,Michael Schaapveld,Renée C. Niessen,Maran J.W. Berends,Rolf H. Sijmons,Robert M.W. Hofstra,Elisabeth G.E. de Vries,Jan H. Kleibeuker	24
13	The VEGF +405 CC Promoter Polymorphism is Associated With an Impaired Prognosis in Patients With Chronic Heart Failure: A MERIT-HF Substudy 2005 ·Journal of Cardiac Failure ·Peter van der Meer,Rudolf A. de Boer,H. L. White,Gerrit van der Steege,Alistair S. Hall,Adriaan A. Voors,Dirk J. van Veldhuisen	49
14	Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma 2005 ·The Lancet ·Arjan Diepstra,Marijke Niens,Edo Vellenga,GW van Imhoff,I Nolte,Michael Schaapveld,Gerrit van der Steege,Anke van den Berg,(unknown),(unknown),S Poppema	110
15	Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease 2005 ·International Journal of Gynecological Cancer ·(unknown),Ilja M. Nolte,M. Schipper,Elvira Oosterom,Gerrit van der Steege,Elisabeth G.E. de Vries,Gerard J. te Meerman,Ate G.J. van der Zee	61
16	Features of epidermolysis bullosa simplex due to mutations in the ectodomain of type XVII collagen 2004 ·British Journal of Dermatology ·Anna M.G. Pasmooij,Gerrit van der Steege,Hendri H. Pas,J.H. Sillevis Smitt,(unknown),(unknown),Marcel F. Jonkman	15
17	Evaluation of the IRF-2 Gene as a Candidate for PSORS3 2004 ·Journal of Investigative Dermatology ·John Foerster,Ilja M. Nolte,Susann Schweiger,(unknown),Marcel Bruinenberg,(unknown),Gerrit van der Steege,Marcel Mulder,Vera M. Kalscheuer,Bettina A. Moser,(unknown),(unknown),Markward Ständer,Wolfram Sterry,Gerard te Meerman	30
18	Deletion of a Cytoplasmic Domain of Integrin β4 Causes Epidermolysis Bullosa Simplex1 2002 ·Journal of Investigative Dermatology ·Marcel F. Jonkman,Hendri H. Pas,Miranda Nijenhuis,(unknown),Gerrit van der Steege	47
19	SMA carrier testing – validation of hemizygous SMN exon 7 deletion test for the identification of proximal spinal muscular atrophy carriers and patients with a single allele deletion 2000 ·European Journal of Human Genetics ·Hans Scheffer,(unknown),Rob G.J. Mensink,Rein P. Stulp,Gerrit van der Steege,Charles H.C.M. Buys	42
20	Linkage and apparent heterogeneity in proximal spinal muscular atrophies 1993 ·Neuromuscular Disorders ·Jan M. Cobben,Hans Scheffer,Marjolein Visser,Jan Osinga,Rune R. Frants,Gerrit van der Steege,Cisca Wijmenga,Leo P. ten Kate,Gert‐Jan B. van Ommen,Charles H.C.M. Buys	8

About Gerrit van der Steege

Gerrit van der Steege is a scholar working on Genetics, Aging and Immunology, having authored 63 papers that have together received 2.4k indexed citations. Recurring topics across this work include Neurogenetic and Muscular Disorders Research (9 papers), Inflammatory Bowel Disease (9 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Aging (71 citations), Genetics (363 citations) and Immunology (636 citations). Gerrit van der Steege has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Ilja M. Nolte, Gerard J. te Meerman, Elvira Oosterom, Hans Scheffer, Dirk J. van Veldhuisen, Rudolf A. de Boer, Alistair S. Hall, Adriaan A. Voors, Marcel Mulder and Pim van der Harst. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact